Terms: = Liver cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1
14 results:
1. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma.
Yu SCY; Deng J; Qiao R; Cheng SH; Peng W; Lau SL; Choy LYL; Leung TY; Wong J; Wong VW; Wong GLH; Jiang P; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2023 Feb; 69(2):168-179. PubMed ID: 36322427
[TBL] [Abstract] [Full Text] [Related]
2. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for cancer Patients.
Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
[TBL] [Abstract] [Full Text] [Related]
3. Rare ATG7 genetic variants predispose patients to severe fatty liver disease.
Baselli GA; Jamialahmadi O; Pelusi S; Ciociola E; Malvestiti F; Saracino M; Santoro L; Cherubini A; Dongiovanni P; Maggioni M; Bianco C; Tavaglione F; Cespiati A; Mancina RM; D'Ambrosio R; Vaira V; Petta S; Miele L; Vespasiani-Gentilucci U; Federico A; Pihlajamaki J; Bugianesi E; Fracanzani AL; Reeves HL; Soardo G; Prati D; Romeo S; Valenti LV;
J Hepatol; 2022 Sep; 77(3):596-606. PubMed ID: 35405176
[TBL] [Abstract] [Full Text] [Related]
4. BRD4 inhibition and FXR activation, individually beneficial in cholestasis, are antagonistic in combination.
Jung H; Chen J; Hu X; Sun H; Wu SY; Chiang CM; Kemper B; Chen LF; Kemper JK
JCI Insight; 2020 Dec; 6(1):. PubMed ID: 33290278
[TBL] [Abstract] [Full Text] [Related]
5. ER-Negative Breast cancer Is Highly Responsive to Cholesterol Metabolite Signalling.
Hutchinson SA; Lianto P; Roberg-Larsen H; Battaglia S; Hughes TA; Thorne JL
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31683867
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/ncor2 axis in hepatocellular carcinoma cells.
Wu Y; Zhou Y; Huan L; Xu L; Shen M; Huang S; Liang L
Cancer Sci; 2019 Mar; 110(3):973-984. PubMed ID: 30680848
[TBL] [Abstract] [Full Text] [Related]
7. Diabetes, metabolic comorbidities, and risk of hepatocellular carcinoma: Results from two prospective cohort studies.
Simon TG; King LY; Chong DQ; Nguyen LH; Ma Y; VoPham T; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Khalili H; Chung RT; Zhang X; Chan AT
Hepatology; 2018 May; 67(5):1797-1806. PubMed ID: 29152763
[TBL] [Abstract] [Full Text] [Related]
8. [Size-based classification of choroidal melanoma and its role in treatment decision-making].
Brovkina AF; Stoyukhina AS; Chesalin IP
Vestn Oftalmol; 2016; 132(2):4-7. PubMed ID: 27213790
[TBL] [Abstract] [Full Text] [Related]
9. Salt-inducible Kinase (SIK1) regulates HCC progression and WNT/β-catenin activation.
Qu C; He D; Lu X; Dong L; Zhu Y; Zhao Q; Jiang X; Chang P; Jiang X; Wang L; Zhang Y; Bi L; He J; Peng Y; Su J; Zhang H; Huang H; Li Y; Zhou S; Qu Y; Zhao Y; Zhang Z
J Hepatol; 2016 May; 64(5):1076-1089. PubMed ID: 26778753
[TBL] [Abstract] [Full Text] [Related]
10. Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.
Song K; Han C; Zhang J; Lu D; Dash S; Feitelson M; Lim K; Wu T
Hepatology; 2013 Nov; 58(5):1681-92. PubMed ID: 23703729
[TBL] [Abstract] [Full Text] [Related]
11. Hdac3 is essential for the maintenance of chromatin structure and genome stability.
Bhaskara S; Knutson SK; Jiang G; Chandrasekharan MB; Wilson AJ; Zheng S; Yenamandra A; Locke K; Yuan JL; Bonine-Summers AR; Wells CE; Kaiser JF; Washington MK; Zhao Z; Wagner FF; Sun ZW; Xia F; Holson EB; Khabele D; Hiebert SW
Cancer Cell; 2010 Nov; 18(5):436-47. PubMed ID: 21075309
[TBL] [Abstract] [Full Text] [Related]
12. A small-molecule inhibitor of Tcf/beta-catenin signaling down-regulates PPARgamma and PPARdelta activities.
Handeli S; Simon JA
Mol Cancer Ther; 2008 Mar; 7(3):521-9. PubMed ID: 18347139
[TBL] [Abstract] [Full Text] [Related]
13. Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs.
Chan IH; Privalsky ML
Oncogene; 2006 Jun; 25(25):3576-88. PubMed ID: 16434963
[TBL] [Abstract] [Full Text] [Related]
14. Impaired interaction of mutant thyroid hormone receptors associated with human hepatocellular carcinoma with transcriptional coregulators.
Lin KH; Wu YH; Chen SL
Endocrinology; 2001 Feb; 142(2):653-62. PubMed ID: 11159836
[TBL] [Abstract] [Full Text] [Related]
